Stay updated on Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:12:59.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added to the history, and earlier items including a government funding notice and revision v3.4.1 were removed.
    Difference
    0.6%
    Check dated 2026-02-11T01:50:14.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding/operating status notice and updated the revision metadata from v3.4.0 to v3.4.1.
    Difference
    0.6%
    Check dated 2026-02-03T23:53:42.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI updates include a glossary toggle, color-coded change highlights (green for additions, red for deletions), and a 'Revision: v3.4.0' label on the history page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-01-27T20:55:17.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision history updated to add v3.3.4 and remove the v3.3.3 entry.
    Difference
    0.1%
    Check dated 2026-01-20T13:55:15.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a new revision entry 'Revision: v3.3.3' to the record history. Removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the page.
    Difference
    0.2%
    Check dated 2025-12-22T22:19:28.000Z thumbnail image

Stay in the know with updates to Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab and Tislelizumab vs Pembrolizumab in Lung Cancer Clinical Trial page.